Literature DB >> 29160955

Synthesis and Biological Evaluation of Pyrrolo[2,1-f][1,2,4]triazine C-Nucleosides with a Ribose, 2'-Deoxyribose, and 2',3'-Dideoxyribose Sugar Moiety.

Qingfeng Li1, Eveline Lescrinier1, Elisabetta Groaz1, Leentje Persoons2, Dirk Daelemans2, Piet Herdewijn1, Steven De Jonghe2.   

Abstract

The synthesis of hitherto unknown pyrrolo[2,1-f][1,2,4]triazine C-nucleosides is described. Structural variations (chlorine, bromine, iodine, and cyano groups) were introduced at position 7 of 4-aza-7,9-dideazaadenine. In addition, pyrrolo[2,1-f][1,2,4]triazine C-nucleosides bearing a 2'-deoxy-, 2',3'-dideoxy-, and 2',3'-dehydrodideoxyribose moiety were also prepared. Among these analogues, the pyrrolo[2,1-f][1,2,4]triazine C-ribonucleosides with either a hydrogen atom or cyano group at position 7 of the nucleobase displayed potent cytotoxic activity in a panel of various cancer cell lines.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  antitumor agents; antiviral agents; drug discovery; nucleosides

Mesh:

Substances:

Year:  2017        PMID: 29160955     DOI: 10.1002/cmdc.201700657

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  3 in total

1.  Synthesis of a 3'-C-ethynyl-β-d-ribofuranose purine nucleoside library: Discovery of C7-deazapurine analogs as potent antiproliferative nucleosides.

Authors:  Fabian Hulpia; Sam Noppen; Dominique Schols; Graciela Andrei; Robert Snoeck; Sandra Liekens; Peter Vervaeke; Serge Van Calenbergh
Journal:  Eur J Med Chem       Date:  2018-07-29       Impact factor: 6.514

2.  Bisubstrate Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 Nsp14 Methyltransferase.

Authors:  Eunkyung Jung; Ruben Soto-Acosta; Jiashu Xie; Daniel J Wilson; Christine D Dreis; Ryuichi Majima; Tiffany C Edwards; Robert J Geraghty; Liqiang Chen
Journal:  ACS Med Chem Lett       Date:  2022-07-22       Impact factor: 4.632

3.  Asymmetric Primaquine and Halogenaniline Fumardiamides as Novel Biologically Active Michael Acceptors.

Authors:  Zrinka Rajić; Maja Beus; Hana Michnová; Josipa Vlainić; Leentje Persoons; Ivan Kosalec; Josef Jampílek; Dominique Schols; Toma Keser; Branka Zorc
Journal:  Molecules       Date:  2018-07-14       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.